OIS Index

OIS-Index-Article

Major Ophthalmic Pipeline Developments Drive OIS Index in July

By Michael Lachman | August 1, 2017

In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…

Read More
OIS-Index-Article

First-Half Performance: OIS Index Tracks US Stock Market but Lags Healthcare Benchmarks

By Michael Lachman | July 5, 2017

We see ophthalmology as one of the more innovative specialties in healthcare, but does that excitement translate to the public markets? In October, we launched…

Read More
OIS-Index-Article

OIS Index Declines in May Despite Positive Pipeline News from Aerie

By Michael Lachman | June 1, 2017

In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…

Read More
OIS-Index-Article

OIS Index Posts Third Straight Positive Month in April

By Michael Lachman | May 1, 2017

In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…

Read More
OIS-Index-Article

OIS Index Tracks Flat US Stock Market and Healthcare Sector Performance in March

By Michael Lachman | March 31, 2017

In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…

Read More
OIS-Index-Article

OIS Index Rebounds – Delivers Positive Performance in February

By Michael Lachman | March 2, 2017

In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…

Read More
OIS-Index-Article

OIS Index Delivers Steadier Performance in January

By Michael Lachman | February 2, 2017

In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…

Read More

OIS Index Underperforms Benchmarks in First Quarter Since Inception

By Michael Lachman | January 5, 2017

In October, OIS partnered with EyeQ Research to launch the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our…

Read More
OIS Index Follows Biotech Stocks Lower in October - OIS Index - Healthegy

OIS INDEX: Trump Bump

By Michael Lachman | November 16, 2016

The OIS Index closed at 962.42 on Tuesday, a week after Donald Trump’s election. Here’s how the collection of 29 publicly traded ophthalmology companies fared…

Read More
OIS Index Follows Biotech Stocks Lower in October - OIS Index - Healthegy

OIS Index Follows Biotech Stocks Lower in October

By Michael Lachman | November 1, 2016

At last month’s OIS@AAO, we introduced the OIS Index. To learn more about its origins and intent, listen to this OIS Podcast interview. By Michael…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.